Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Juliana Vergara"'
Autor:
Roman M. Shapiro, Grace C. Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska, Alaa K. Ali, Mubin Tarannum, Michal Sheffer, Yasmin Z. Abdulhamid, Benedetta Rambaldi, Yohei Arihara, Carol Reynolds, Max S. Halpern, Scott J. Rodig, Nicole Cullen, Jacquelyn O. Wolff, Kathleen L. Pfaff, Andrew A. Lane, R. Coleman Lindsley, Corey S. Cutler, Joseph H. Antin, Vincent T. Ho, John Koreth, Mahasweta Gooptu, Haesook T. Kim, Karl-Johan Malmberg, Catherine J. Wu, Jianzhu Chen, Robert J. Soiffer, Jerome Ritz, Rizwan Romee
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 11 (2022)
Background Responses to conventional donor lymphocyte infusion for postallogeneic hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell–based therapy is a promising modality to treat post-HCT relapse.Methods
Externí odkaz:
https://doaj.org/article/2699fa01730746f2b44f722f69c72b21
Autor:
Sabrin Tahri, Nang Kham Su, Luisa Maria Lampe, Han Dong, Juliana Vergara Cadavid, Natalie Papazian, Amanda Cao, Jean-Baptiste Alberge, Lucas Ferrari de Andrade, Mahshid Rahmat, Yujia Shen, Rebecca Boiarsky, Laura Blanco, Bruno Paiva, Andreas Guenther, Gad Getz, Pieter Sonneveld, Tom Cupedo, Kai W. Wucherpfennig, Irene Ghobrial, Rizwan Romee
Publikováno v:
Blood. 140:4204-4206
Autor:
Juliana Vergara-Cadavid, P. Connor Johnson, Haesook T. Kim, Alisha Yi, Meghan E. Sise, David E. Leaf, Paul E. Hanna, Vincent T. Ho, Corey S. Cutler, Joseph H. Antin, Mahasweta Gooptu, Amar H. Kelkar, Sophia L. Wells, Sarah Nikiforow, John Koreth, Rizwan Romee, Robert J. Soiffer, Roman M. Shapiro, Shruti Gupta
Publikováno v:
Transplantation and Cellular Therapy.
Autor:
Han Dong, James Dongjoo Ham, Guangan Hu, Guozhu Xie, Juliana Vergara, Yong Liang, Alaa Ali, Mubin Tarannum, Hannah Donner, Joanna Baginska, Yasmin Abdulhamid, Khanhlinh Dinh, Robert J. Soiffer, Jerome Ritz, Laurie H. Glimcher, Jianzhu Chen, Rizwan Romee
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Acute myeloid leukemia (AML) remains a therapeutic challenge, and a paucity of tumor-specific targets has significantly hampered the development of effective immune-based therapies. Recent paradigm-changing studies have shown that natural killer (NK)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Research. 83:3181-3181
Epithelial ovarian cancer (OVC) is the leading cause of death among gynecological malignancies. Natural killer (NK) cells are an attractive platform for immunotherapy owing to their superior safety, multiple mechanisms of cytotoxicity, and reduced ri
Autor:
Sabrin Tahri, Nang Kham Su, Luisa Lampe, Han Dong, Juliana Vergara Cadavid, Natalie Papazian, Amanda Cao, Jean-Baptiste Alberge, Lucas Ferrari de Andrade, Mahshid Rahmat, Yujia Shen, Rebecca Boiarsky, Laura Blanco, Bruno Paiva, Andreas Günther, Gad Getz, Pieter Sonneveld, Kai Wucherpfennig, Tom Cupedo, Irene Ghobrial, Romee Rizwan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S47-S48
Autor:
Laura Ceballos Ramírez, Octavio Germán Muñoz Maya, Juan Ignacio Marín Zuluaga, Juliana Vergara Cadavid, Liliana Cajiao Castro, Gabriel Sebastián Díaz Ramírez, Susana Castro Sánchez, Danny Arroyave Zuluaga
Publikováno v:
Hepatología. :134-144
Introducción. El carcinoma hepatocelular (CHC) en los pacientes con cirrosis hepática es una indicación frecuente de trasplante de hígado y una causa de muerte por diagnóstico tardío. El objetivo de este estudio fue describir las característic
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jerome Ritz, Sarah Nikiforow, Juliana Vergara, Joseph H. Antin, Jianzhu Chen, Carol Reynolds, Grace Birch, Robert J. Soiffer, John Koreth, Corey Cutler, Guangan Hu, Alaa Kassim Ali, Benedetta Rambaldi, Scott J. Rodig, Catherine J. Wu, Vincent T. Ho, Nicole Cullen, Haesook T. Kim, R. Coleman Lindsley, Joanna Baginska, Yohei Arihara, Mahasweta Gooptu, Mubin Tarannum, Karl-Johan Malmberg, Roman M Shapiro, Andrew A. Lane, Rizwan Romee, Max Halpern
BackgroundResponses to conventional donor lymphocyte infusion (DLI) for post-allogeneic hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell-based therapy is a promising modality to treat post-HCT relapse.Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::421e4221047322fcb801bc949a0a5be0
https://doi.org/10.1101/2021.08.24.21262547
https://doi.org/10.1101/2021.08.24.21262547